| Title |
Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, September 2014
|
| DOI | 10.2147/tcrm.s68450 |
| Pubmed ID | |
| Authors |
Habip Gedik, Funda Şimşek, Arzu Kantürk, Taner Yildirmak, Deniz Arica, Demet Aydin, Naciye Demirel, Osman Yokuş |
| Abstract |
The primary objective of this study was to report the incidence of bloodstream infections (BSIs) and clinically or microbiologically proven bacterial or fungal BSIs during neutropenic episodes in patients with hematological malignancies. |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 107 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 13% |
| Student > Postgraduate | 12 | 11% |
| Student > Bachelor | 11 | 10% |
| Student > Master | 10 | 9% |
| Other | 9 | 8% |
| Other | 22 | 20% |
| Unknown | 31 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 39% |
| Biochemistry, Genetics and Molecular Biology | 9 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Agricultural and Biological Sciences | 6 | 6% |
| Immunology and Microbiology | 4 | 4% |
| Other | 8 | 7% |
| Unknown | 33 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2016.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Therapeutics and Clinical Risk Management
#1,204
of 1,323 outputs
Outputs of similar age
#213,027
of 248,671 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#13
of 15 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,671 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.